1
Clinical Trials associated with TpdelansbsalbacA Phase I/II Clinical Study of the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in the Treatment of Malignant Pleural and Abdominal Effusions
This is a Phase I/II, open, first-in-human (FIH) study of Transebacillus in Patients with malignant pleural and abdominal effusions. It consists of Phase Ia to determine the Maximum tolerated dose (MTD) or Recommended Phase 2 dose (RP2D) of Transebacillus, and Phase Ib/II to explore and confirm the efficacy, safety and Tolerability.
100 Clinical Results associated with Tpdelansbsalbac
100 Translational Medicine associated with Tpdelansbsalbac
100 Patents (Medical) associated with Tpdelansbsalbac
100 Deals associated with Tpdelansbsalbac